Who is sponsoring NCT04420663?

NCT04420663 is sponsored by Aly Sherif Hassaballa.

What drugs are being tested in NCT04420663?

Interventions in NCT04420663: Pleural Manometry.

What condition does NCT04420663 study?

NCT04420663 studies Thoracocentesis of Pleural Effusion.

Is NCT04420663 still recruiting?

NCT04420663 is currently completed. Last updated 1 April 2022.

Last reviewed 2022-04-01 · How we verify

NCT04420663

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Pleural Manometry in Thoracocentesis

Completed NA Last updated 1 April 2022

What this trial tests

NA trial testing Pleural Manometry in Thoracocentesis of Pleural Effusion in 110 participants. Completed in 31 December 2021.

Timeline

1 July 2019

Primary endpoint
31 December 2021

31 December 2021

Quick facts

Lead sponsor	Aly Sherif Hassaballa
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	diagnostic
Enrollment	110
Start date	1 July 2019
Primary completion	31 December 2021
Estimated completion	31 December 2021
Sites	1 location across Egypt

Drugs / interventions tested

Pleural Manometry

Conditions studied

Thoracocentesis of Pleural Effusion — all drugs for Thoracocentesis of Pleural Effusion →

Sponsor

Aly Sherif Hassaballa

Who can join

Adults 18 to 85, any sex, with Thoracocentesis of Pleural Effusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aiming to measure the pleural pressure during thoracocentesis in patients with pleural effusion and the value of their measurement in both diagnostic and therapeutic decisions.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Pleural manometry during thoracocentesis in patients with malignant pleural effusion: A randomized controlled trial.
Hassaballa AS, Mostafa A, Hikal T, Elnori A, et al · · 2023 · cited 2× · PMID 36741303 · DOI 10.29390/cjrt-2022-047
Pleural manometry during thoracocentesis in patients with malignant pleural effusion: A randomized controlled trial
Hassaballa AS, Mostafa A, Haikal T, Elnori A, et al · · 2022 · DOI 10.21203/rs.3.rs-1541291/v1

Verify or expand the search:

Other trials of Pleural Manometry

Trials testing the same drug.

NCT01973985 — Using Ultrasound to Predict the Results of Draining Pleural Effusions · terminated

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04420663 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Aly Sherif Hassaballa
Last refreshed: 1 April 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04420663.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing